Bioactive Compounds
-
BA1966 BDM-2Summary: BDM-2 is an IN-LEDGF-altering inhibitor (INLAI) of integrase (=47nM) and has potent antiretroviral (ARV) activity. -
BA1965 Clathrin-IN-1Summary: Clathrin-IN-1 is a selective inhibitor of lattice protein-mediated endocytosis. - BA1964 NBD-14189Summary: NBD-14189 is a potent entry antagonist.
- BA1963 NBD-14270Summary: NBD-14270, a pyridine analog, is a potent entry antagonist.
- BA1961 NBD-557Summary: HIV-1 inhibitors.
- BA1960 ElipovimabSummary: Elipovimab is a potent broadly neutralizing HIV-1 antibody for targeting and eliminating infected cells.
- BA1959 AzddMeCSummary: AzddMeC (CS-92) is an antiviral nucleoside analog and a potent, selective, orally active inhibitor of reverse transcriptase and replication.
- BA1958 PeldesineSummary: Peldesine (BCX34) is a potent, competitive, reversible and orally active purine nucleoside phosphorylase inhibitor.
- BA1957 NipamovirSummary: Nipamovir is a nitroimidazole prodrug.
- BA1956 AtevirdineSummary: Atevirdine is a potent non-nucleoside HIV-1 reverse transcriptase inhibitor.